GlassScriptPhysician profile
John D Easton
NPI 1043254329
$111,661.71
in general payments reported to CMS, 2019-2025
9 companies · $7,313 in 2025
The $7,313 reported for 2025 was more than what 87% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $42K · 2021: $22K · 2022: $15K · 2023: $2,138 · 2024: $3,600 · 2025: $7,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,050.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $35,157.20 | 2020-2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $28,800.40 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $14,140.00 | 2020-2021 | |
| Janssen Research & Development, LLC | $13,050.00 | 2023-2025 | |
| Boehringer Ingelheim International Gmbh | $7,393.50 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $4,610.61 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,850.00 | 2019 | |
| Sunovion Pharmaceuticals INC. | $3,400.00 | 2019 | |
| Daiichi Sankyo INC. | $1,260.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Easton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.